Mesoblast (MESO) Assets Average (2015 - 2025)

Mesoblast's (MESO) quarterly Assets Average came in at $783.5 million in Q4 2025, up 18.49% year-on-year from $661.2 million in Q4 2024, and up 8.97% quarter-over-quarter from $719.0 million in Q2 2025.

Mesoblast (MESO) Assets Average (2015 - 2025) Analysis & Trends

Mesoblast has disclosed Assets Average across 11 years of filings, most recently posting $783.5 million for Q4 2025.

  • Assets Average for Q4 2025 came in at $783.5 million, up 18.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $783.5 million (up 18.49% YoY), and the FY2025 annual result was $726.9 million, up 8.61% from the prior year.
  • Assets Average came in at $783.5 million for Q4 2025 at Mesoblast, up from $719.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $783.5 million in Q4 2025 to a low of $659.3 million in Q1 2023.
  • The 5-year median for Assets Average is $676.3 million (2022), against an average of $697.7 million.
  • Across the five-year window, Assets Average fell 11.05% in 2022 and grew 18.49% in 2025, its largest moves.
  • Mesoblast's Assets Average stood at $713.1 million in 2021, then dropped by 5.17% to $676.3 million in 2022, then dropped by 0.95% to $669.8 million in 2023, then slipped by 1.29% to $661.2 million in 2024, then advanced by 18.49% to $783.5 million in 2025.
  • The last three Assets Average figures came in at $783.5 million (Q4 2025), $719.0 million (Q2 2025), and $661.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 33.42 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13.04 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.72 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 26.03 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 40.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.06 Bn
9 Abivax 91.96 Bn 91.96 Bn - 660.38 Mn
10 Mesoblast 21.68 Bn 21.55 Bn - 783.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 783.50 Mn
Jun 30, 2025 719.00 Mn
Dec 31, 2024 661.24 Mn
Jun 30, 2024 669.72 Mn
Dec 31, 2023 669.85 Mn
Jun 30, 2023 659.93 Mn
Mar 31, 2023 659.25 Mn
Dec 31, 2022 676.28 Mn
Sep 30, 2022 673.32 Mn
Jun 30, 2022 671.92 Mn
Mar 31, 2022 693.06 Mn
Dec 31, 2021 713.13 Mn
Sep 30, 2021 733.27 Mn
Jun 30, 2021 755.42 Mn
Mar 31, 2021 726.72 Mn
Dec 31, 2020 699.94 Mn
Sep 30, 2020 723.09 Mn
Jun 30, 2020 699.70 Mn
Mar 31, 2020 678.01 Mn
Dec 31, 2019 672.01 Mn